Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 3 trials
New formulations, regulatory evaluations, and continuous clinical trials will probably shape future peptide treatment
You have tried moisturizers
Its original discovery and primary research focus centers on gastric and intestinal tissue repair
Quick Facts TypePeptide Blend (BPC-157 + TB-500) CategoryRecovery / Tissue Repair AdministrationSubcutaneous injection FrequencyDaily (loading) / 3x weekly (maintenance) Typical Dose250500 mcg of each per dose Cycle Length48 weeks Available Sizes5 mg/5 mg (10 mg total) vials Stability21 days after reconstitution Overview What is the BPC-157 / TB-500 Blend
US$ 28.21
US$ 25.01
US$ 23.20
US$ 24.76
